China Resources Boya Bio-pharmaceutical Group Co.,Ltd 300294.SZ Stock
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Price Chart
China Resources Boya Bio-pharmaceutical Group Co.,Ltd 300294.SZ Financial and Trading Overview
Contents
- China Resources Boya Bio-pharmaceutical Group Co.,Ltd Price Chart
- China Resources Boya Bio-pharmaceutical Group Co.,Ltd 300294.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of China Resources Boya Bio-pharmaceutical Group Co.,Ltd
- Q&A For China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd stock price | 30.81 CNY |
| Previous Close | 37.54 CNY |
| Open | 37.6 CNY |
| Bid | 37.43 CNY x 0 |
| Ask | 37.45 CNY x 0 |
| Day's Range | 37.36 - 38.05 CNY |
| 52 Week Range | 29.31 - 39.21 CNY |
| Volume | 2.31M CNY |
| Avg. Volume | 4.12M CNY |
| Market Cap | 18.88B CNY |
| Beta (5Y Monthly) | 0.386986 |
| PE Ratio (TTM) | 37.81818 |
| EPS (TTM) | 0.47 CNY |
| Forward Dividend & Yield | 0.2 (0.53%) |
| Ex-Dividend Date | April 28, 2023 |
| 1y Target Est | N/A |
300294.SZ Valuation Measures
| Enterprise Value | 14.08B CNY |
| Trailing P/E | 37.81818 |
| Forward P/E | 28.150373 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.4876714 |
| Price/Book (mrq) | 2.5664928 |
| Enterprise Value/Revenue | 4.837 |
| Enterprise Value/EBITDA | 22.364 |
Trading Information
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock Price History
| Beta (5Y Monthly) | 0.386986 |
| 52-Week Change | 13.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 39.21 CNY |
| 52 Week Low | 29.31 CNY |
| 50-Day Moving Average | 37.26 CNY |
| 200-Day Moving Average | 34.83 CNY |
300294.SZ Share Statistics
| Avg. Volume (3 month) | 4.12M CNY |
| Avg. Daily Volume (10-Days) | 2.85M CNY |
| Shares Outstanding | 504.25M |
| Float | 270.44M |
| Short Ratio | N/A |
| % Held by Insiders | 36.40% |
| % Held by Institutions | 21.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.53% |
| 5 Year Average Dividend Yield | 41.00% |
| Payout Ratio | 0.1515 |
| Last Split Factor | 15:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 17.14% |
| Operating Margin (ttm) | 18.55% |
| Gross Margin | 52.52% |
| EBITDA Margin | 21.62% |
Management Effectiveness
| Return on Assets (ttm) | 4.25% |
| Return on Equity (ttm) | 7.09% |
Income Statement
| Revenue (ttm) | 2.91B CNY |
| Revenue Per Share (ttm) | 5.77 CNY |
| Quarterly Revenue Growth (yoy) | 23.10% |
| Gross Profit (ttm) | 1.5B CNY |
| EBITDA | 629.39M CNY |
| Net Income Avi to Common (ttm) | 498.96M CNY |
| Diluted EPS (ttm) | 0.99 |
| Quarterly Earnings Growth (yoy) | 64.50% |
Balance Sheet
| Total Cash (mrq) | 4.94B CNY |
| Total Cash Per Share (mrq) | 9.79 CNY |
| Total Debt (mrq) | 12.58M CNY |
| Total Debt/Equity (mrq) | 0.17 CNY |
| Current Ratio (mrq) | 8.547 |
| Book Value Per Share (mrq) | 14.588 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 796.97M CNY |
| Levered Free Cash Flow (ttm) | 569.12M CNY |
Profile of China Resources Boya Bio-pharmaceutical Group Co.,Ltd
| Country | China |
| State | N/A |
| City | Fuzhou |
| Address | No. 333, Huiquan Road |
| ZIP | 344000 |
| Phone | 86 79 4826 4398 |
| Website | https://www.china-boya.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin sodium injections for various fields, such as medicine, hepatitis, gynecology, and immunomodulation. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Fuzhou, China.
Q&A For China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock
What is a current 300294.SZ stock price?
China Resources Boya Bio-pharmaceutical Group Co.,Ltd 300294.SZ stock price today per share is 30.81 CNY.
How to purchase China Resources Boya Bio-pharmaceutical Group Co.,Ltd stock?
You can buy 300294.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Resources Boya Bio-pharmaceutical Group Co.,Ltd?
The stock symbol or ticker of China Resources Boya Bio-pharmaceutical Group Co.,Ltd is 300294.SZ.
Which industry does the China Resources Boya Bio-pharmaceutical Group Co.,Ltd company belong to?
The China Resources Boya Bio-pharmaceutical Group Co.,Ltd industry is Biotechnology.
How many shares does China Resources Boya Bio-pharmaceutical Group Co.,Ltd have in circulation?
The max supply of China Resources Boya Bio-pharmaceutical Group Co.,Ltd shares is 504.25M.
What is China Resources Boya Bio-pharmaceutical Group Co.,Ltd Price to Earnings Ratio (PE Ratio)?
China Resources Boya Bio-pharmaceutical Group Co.,Ltd PE Ratio is 65.55319000 now.
What was China Resources Boya Bio-pharmaceutical Group Co.,Ltd earnings per share over the trailing 12 months (TTM)?
China Resources Boya Bio-pharmaceutical Group Co.,Ltd EPS is 0.47 CNY over the trailing 12 months.
Which sector does the China Resources Boya Bio-pharmaceutical Group Co.,Ltd company belong to?
The China Resources Boya Bio-pharmaceutical Group Co.,Ltd sector is Healthcare.